Skip to main content
. 2022 Jun 28;15:11786469221096643. doi: 10.1177/11786469221096643

Table 1.

Implication of tryptophan/kynurenine pathway in the survival of heart transplantation.

Author Human/animal Method Findings
Suarez-Fuentetaja et al 158 Human An observational study measuring serum IDO activity in patients with heart transplantation Patients with acute rejection had higher IDO serum activity after 1 month of transplantation. Also, IDO serum activity independently (95% CI, OR 1.4 [1.033-1.876]) predicted graft rejection among patients with heart transplantation
Li et al 164 Mouse Treating animals with dendritic cells transfected with adenovirus vector carrying IDO gene IDO overexpression improved survival, postponed graft rejection, reduced IFN-γ production, and accelerated CD4+ cell death
He et al 162 Rat Treating animals with bone marrow stem cells transfected with lentiviral vector carrying IDO gene IDO overexpression prolonged survival, enhanced ejection fraction, decreased CD86+, CD80+ cells, MHC II, IL2 and IFN-γ and increased T Reg cells abundance and the expression of CD274, IL10, TGF-β1, TGF-β2, TGF-β3 in the heart allograft
Yang et al 159 Rat Treating rats with immutol, cyclosporine and 1-MT 1-MT significantly blocked kynurenine pathway and decreased graft survival. Activation of kynurenine pathway has been associated with increased abundance of T Reg cells, higher concentrations of IL10, and TGF-β, as well as decreased abundance of CD8+ cells
Dai et al 171 Rat A single-dose intravenous administration of 3-hydroxyanthranilic acid + allogeneic dendritic cells 7 days before heart transplantation Pretreatment with the combination of 3-hydroxyanthranilic acid + allogeneic dendritic cells enhanced cardiac allograft survival and suppressed T cells activity
Lv et al 161 Mouse Treating mice with dendritic cells transfected with adenovirus vector carrying IDO gene IDO overexpression enhanced both cardiac graft survival and function. Higher IL10/IL6 ratio and lower levels of IFN-γ and IL-2 were found in treated group
Li et al 170 Mouse Transferring tolerogenic dendritic cells from a tolerant recipient to secondary recipient in mice heart transplantation model Tolerogenic dendritic cells transfer from a tolerant recipient to another recipient significantly enhanced IDO expression, induced T Reg differentiation, suppressed anti-donor T cells activity and increased graft survival in the secondary recipient
Li et al 172 Mouse Treating mice with intravenous injection of tryptophan catabolic metabolites, dendritic cells transfected with adenovirus vector carrying IDO gene and their combination Treating mice with tryptophan catabolic metabolites or adenoviral transfected dendritic cells significantly increased cardiac graft survival, decreased IL2, TNF-α and IFN-γ and increased IL10. Significantly greater improvement was observed in combination therapy
Yu et al 169 Mouse Cardiac allograft injection with adenovirus vector carrying IDO gene. Higher IDO expression was detected in treated mice. Increased IDO expression was associated with decreased expression of IL2, IL17, and IFN-γ. IDO enhanced T Reg cells differentiation and prolonged graft survival
He et al 166 Rat Intravenous injection of DO1-BMSC-exosomes 48 h after heart transplantation Treated rats showed better cardiac function. Treatment with DO1-BMSC-exosomes augmented T Reg response and suppressed CD8+ response
Li et al 176 Mouse Measuring microRNAs in mice cardiac transplantation and assessing their effect on cardiac allograft rejection and IDO expression miR-669b-3p decreased IDO expression, thereby expediting graft rejection
Sucher et al 167 Mouse Treating heart transplanted mice with cytotoxic T lymphocyte-associated antigen-4 Ig (CTLA4Ig) CTLA4Ig promoted IDO expression, thereby increasing graft survival. IDO gene deletion accelerated graft rejection. Furthermore, IDO inhibition since transplantation or 50 days after transplantation attenuated the beneficial effects of CTLA4Ig on graft survival. In addition, T Reg cells depletion impairs CTLA4Ig-mediated graft survival
Zhang et al 165 Mouse Intravenous injection of dendritic cells transfected with adenovirus vector carrying GDF15 gene 7 days before transplantation GDF15 overexpression upregulated IDO in dendritic cells, thereby inducing tolerance in T cells and delaying graft rejection